THe Australian Self-Medication
Industry has vowed to continue
its advocacy for Schedule 3
advertising reforms, in the face of
recommendations that restrictions
be retained in the State Two Expert
Panel report on the regulatory
framework for medicines and
medical devices (PD Fri).
The above snippet is the first part of an article sent to subscribers in Pharmacy Daily's issue from 23 Nov 15
To see the full story, see the embedded issue below or CLICK HERE to download Pharmacy Daily from 23 Nov 15
